Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/OR/Salem
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Salem, OR

Studies commonly pay $75 to $4,500 per completed study

112 clinical trials are currently recruiting participants within 30 miles of Salem. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

112studies recruiting
6+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Salem right now

Top 25 of 112 recruiting studies, sorted by proximity — each links to its official registry page

Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors

Gynecologic Cancers, Breast Cancer Phase 1 Interventional 60 participants sought
Samaritan Pastega Regional Cancer Center — Corvallis, Oregon (27.4 mi) · Sponsor: Oregon State University

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Breast Neoplasms, Neoplasm Metastasis Phase 3 Interventional 800 participants sought
Good Samaritan Regional Medical Center — Corvallis, Oregon (27.4 mi) · Sponsor: Eli Lilly and Company

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

Sepsis, Acute Kidney Injury Phase 2 Interventional 124 participants sought
Research Site — Corvallis, Oregon (27.4 mi) · Sponsor: AstraZeneca

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: NRG Oncology

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Salem Hospital — Salem, Oregon (1.5 mi) · Sponsor: SWOG Cancer Research Network

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: National Cancer Institute (NCI)

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: SWOG Cancer Research Network

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Multiple conditions Phase 2 Interventional 120 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: National Cancer Institute (NCI)

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Myelodysplastic Syndromes, Acute Myeloid Leukemia Phase 2, Phase 3 Interventional 316 participants sought
Oregon Oncology Specialists — Salem, Oregon (1.5 mi) · Sponsor: Taiho Oncology, Inc.

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prostate Cancer (Adenocarcinoma) Phase 3 Interventional 830 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: Canadian Cancer Trials Group

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 626 participants sought
Oregon Oncology Specialists — Salem, Oregon (1.5 mi) · Sponsor: Mirati Therapeutics Inc.

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 3 Interventional 382 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 306 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: National Cancer Institute (NCI)

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Rectal Cancer Phase 3 Interventional 250 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: Canadian Cancer Trials Group

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma Phase 2, Phase 3 Interventional 189 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: National Cancer Institute (NCI)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: National Cancer Institute (NCI)

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Intestinal Neoplasms, Gastrointestinal Neoplasms Phase 3 Interventional 800 participants sought
Oncology Associates of Oregon, P.C. — Albany, Oregon (20.2 mi) · Sponsor: Pfizer

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Phase 2 Interventional 112 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: SWOG Cancer Research Network

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8 Phase 2 Interventional 44 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: SWOG Cancer Research Network

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
Salem Hospital — Salem, Oregon (1.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

Non-squamous Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Salem, Oregon (1.5 mi) · Sponsor: AstraZeneca

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Phase 3 Interventional 94 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: SWOG Cancer Research Network
Actively enrolling

Studies you may be able to join near Salem

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Salem

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

OSH Museum of Mental Health

★ 4.6
2600 Center St NE, Salem, OR 97301
(971) 599-1674
"Easy to follow lay out. Beautiful grounds"
— Shelly Marlow, 5★

Oregon Medical Research Center

★ 4.4
1750 S Harbor Way Unit 330, Portland, OR 97201
(503) 245-1525
"Fantastic start to finish. The Staff at OMRC were kind, professional, helpful, informative, and were the first healthcare providers to believe me and…"
— Amy Pettinger, 5★

The Corvallis Clinic - Clinical Research Center

★ 5.0
The Corvallis Clinic, Asbury Building, 3680 NW Samaritan Dr, Corvallis, OR 97330
(541) 766-2163

Legacy Research Institute

★ 4.4
1225 NE 2nd Ave, Portland, OR 97232
(503) 413-2491
"Safe place to get help, PES is a little uncomfortable but they get you a bed as fast as they can and the nurses are almost all nice"
— Lukas, 4★

Summit Research Network Oregon, Inc.

★ 4.6
2701 NW Vaughn St #350, Portland, OR 97210
(503) 279-8252
"The entire staff from the front dest to the lab lady's, doctors, and medical assistants are extremely compationate and friendly."
— Valerie Carter, 5★

Northwest Research Center

★ 5.0
6327 SE Milwaukie Ave, Portland, OR 97202
(503) 238-6233

Clinical trials in Salem: what's recruiting

The Salem area currently has 112 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Salem, the most active research areas are:

  • Cancer & Oncology21 studies
  • Liver & Kidney1 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Salem, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Salem

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Salem participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Salem?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Salem safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Salem?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Salem?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Salem.

Paid clinical trials near Salem

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of OR

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts